Esperion Therapeutics Inc
Top 10 Superinvestors by Shares Owned
This chart shows the top 10 superinvestors based on the number of shares they owned in 2024-Q2 and 2024-Q3. According to the most recent SEC 13F filing, 17 superinvestors own shares of Esperion Therapeutics Inc (29664WAB1), although recent data may remain incomplete due to pending filings.
Quarter-over-Quarter Change (%)
This chart highlights the quarter-over-quarter change (%) in the number of superinvestors holding Esperion Therapeutics Inc (29664WAB1), the total shares they held, and the total reported dollar value. It gives a clear view of whether there is ongoing momentum. The dotted lines at the top and bottom adjust longer bars to keep smaller data points visible for better comparison.
Superinvestors' Activity (%) Over the Last 4 Quarters
This chart shows superinvestors' activity with Esperion Therapeutics Inc (29664WAB1) over the last four quarters, highlighting the percentage of investors who added, increased, decreased, held, or exited their positions, revealing shifts in sentiment over time.
Superinvestors' Past Actions
This chart displays superinvestors' past actions with Esperion Therapeutics Inc (29664WAB1) over the last 10 years (40 quarters), helping to visualize the collective momentum and investment trends over time.
Superinvestors ownership
Superinvestor | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
Anthony Gonzalez@Davidson Kempner Capital Management Lp
| 0.65% | $23.703M 25M shares@ 0.95 avg price | Decreased -16.66% |
Michael G. Clarke@Ameriprise Financial Inc
| 0.01% | $5.689M 6M shares@ 0.95 avg price | Decreased -25% |
Lawrence V. Palermo@Two Seas Capital Lp
| 0.82% | $5.042M 5.315M shares@ 0.95 avg price | Decreased -73.83% |
David Sven Floren@Dcf Advisers, Llc
| 0.86% | $2.134M 2.25M shares@ 0.95 avg price | Decreased -11.76% |
Grace Brescia@Context Capital Management, Llc
| 1.25% | $45.635M 47,879 shares@ 953.13 avg price | Decreased -6.58% |